Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents

Cancer Letters

Volumn 232, Issue 2, 2006, Pages 236-242

  Cheng, Chen Li ^b   Chen, Kuo Jung ^b   Shih, Po Hung ^a   Lu, Lieng Yi ^b   Hung, Chia Fang ^b   Lin, Wen Ching ^b   Yesong Gu, Jason ^a  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Aristolochic acid; Chronic renal failure; ras proto oncogene; RFLP

Indexed keywords

ARISTOLOCHIC ACID; CARCINOGEN; CREATININE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CODON; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE MUTATION; NEPHROTOXICITY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH; WEIGHT GAIN;

ANIMALS; ARISTOLOCHIC ACIDS; CREATININE; DNA ADDUCTS; GENES, RAS; KIDNEY; KIDNEY FAILURE, CHRONIC; NEOPLASMS; POINT MUTATION; RATS; RATS, WISTAR;

ANIMALIA;

EID: 31644439699     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.02.021     Document Type: Article

References (37)

1. S.M. Kupchan, and R.W. Doskotch Tumor inhibitors: I. Aristolochic acid, the active principle of Aristolochia indica J. Med. Pharm. Chem. 5 1962 657 659
2. J.R. Mose The effect of aristolochic acid on the development of methyl-cholanthrene tumours in mice Osterr. Kneipp. Mag. 2 1975 151 153
3. J.J. Moreno Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation Immunopharmacology 26 1993 1 9
4. V.M. Arlt, M. Stiborova, and H.H. Schmeiser Aristolochic acid as a probable human cancer hazard in herbal remedies: a review Mutagenesis 17 2002 265 277
5. J.P. Cosyns Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date Drug Saf. 26 2003 33 48
6. J.L. Vanherweghem, M. Depierreux, C. Tielemans, D. Abramowicz, M. Dratwa, and M. Jadoul Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs Lancet 341 1993 387 391
7. G.M. Lord, R. Tagore, T. Cook, P. Gower, and C.D. Pusey Nephropathy caused by Chinese herbs in the UK Lancet 354 1999 481 482
8. B. Stengel, and E. Jones End-stage renal insufficiency associated with Chinese herbal consumption in France Nephrologie 19 1998 15 20
9. U. Mengs, and C.D. Stotzem Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology Arch. Toxicol. 67 1993 307 311
10. J.P. Cosyns, J.P. Dehoux, Y. Guiot, R.M. Goebbels, A. Robert, and A.M. Bernard Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int. 59 2001 2164 2173
11. M.C. Liu, S. Maruyama, M. Mizuno, Y. Morita, S. Hanaki, and Y. Yuzawa The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids Clin. Exp. Nephrol. 7 2003 186 194
12. U. Mengs On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid Arch. Toxicol. 52 1983 209 220
13. U. Mengs Tumour induction in mice following exposure to aristolochic acid Arch. Toxicol. 61 1988 504 505
14. J.P. Cosyns, R.M. Goebbels, V. Liberton, H.H. Schmeiser, C.A. Bieler, and A.M. Bernard Chinese herbs nephropathy-associated slimming regimen induces tumours in the forestomach but no interstitial nephropathy in rats Arch. Toxicol. 72 1998 738 743
15. H.H. Schmeiser, K.B. Schoepe, and M. Wiessler DNA adduct formation of aristolochic acid I and II in vitro and in vivo Carcinogenesis 9 1988 297 303
16. M. Stiborova, R.C. Fernando, H.H. Schmeiser, E. Frei, W. Pfau, and M. Wiessler Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures Carcinogenesis 15 1994 1187 1192
17. W. Pfau, H.H. Schmeiser, and M. Wiessler 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II Carcinogenesis 11 1990 1627 1633
18. H.H. Schmeiser, C.A. Bieler, M. Wiessler, C. van Ypersele de Strihou, and J.P. Cosyns Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy Cancer Res. 56 1996 2025 2028
19. T.H. Broschard, M. Wiessler, and H.H. Schmeiser Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha Cancer Lett. 98 1995 47 56
20. T.H. Broschard, M. Wiessler, C.W. von der Lieth, and H.H. Schmeiser Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid Carcinogenesis 15 1994 2331 2340
21. H.H. Schmeiser, J.W. Janssen, J. Lyons, H.R. Scherf, W. Pfau, and A. Buchmann Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues Cancer Res. 50 1990 5464 5469
22. Z. Liu, M. Hergenhahn, H.H. Schmeiser, G.N. Wogan, A. Hong, and M. Hollstein Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene Proc. Natl Acad. Sci. USA 101 2004 2963 2968
23. J.P. Cosyns, M. Jadoul, J.P. Squifflet, F.X. Wese, and C. van Ypersele de Strihou Urothelial lesions in Chinese-herb nephropathy Am. J. Kidney Dis. 33 1999 1011 1017
24. J.L. Nortier, H.H. Schmeiser, M.C. Muniz Martinez, V.M. Arlt, C. Vervaet, and C.H. Garbar Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure Nephrol. Dial. Transplant 18 2003 426 428
25. M. Vanhaelen, R. Vanhaelen-Fastre, P. But, and J.L. Vanherweghem Identification of aristolochic acid in Chinese herbs Lancet 343 1994 174
26. Y. Satomi, P. Bu, M. Okuda, H. Tokuda, and H. Nishino H-ras mutations at codon 61 or 13 in tumors initiated with a NO donor in mouse skin Cancer Lett. 196 2003 17 22
27. V.L. Wilson, Q. Wei, K.R. Wade, M. Chisa, D. Bailey, and C.M. Kanstrup Needle-in-a-haystack detection and identification of base substitution mutations in human tissues Mutat. Res. 406 1999 79 100
28. H.H. Schmeiser, H.R. Scherf, and M. Wiessler Activating mutations at codon 61 of the c-Ha-ras gene in thin-tissue sections of tumors induced by aristolochic acid in rats and mice Cancer Lett. 59 1991 139 143
29. V.M. Arlt, M. Wiessler, and H.H. Schmeiser Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene Carcinogenesis 21 2 2000 235 242
30. J.R. Ioset, G.E. Raoelison, and K. Hostettmann Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens Food Chem. Toxicol. 41 2003 29 36
31. J.L. Nortier, and J.L. Vanherweghem Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) Toxicology 181/182 2002 577 580
32. B.A. Schwetz Safety of aristolochic acid J. Am. Med. Assoc. 285 2001 2705
33. S. Zhou, H.L. Koh, Y. Gao, Z.Y. Gong, and E.J. Lee Herbal bioactivation: the good, the bad and the ugly Life Sci. 74 2004 935 968
34. V.M. Arlt, H.H. Schmeiser, and G.P. Pfeifer Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR Carcinogenesis 22 2001 133 140
35. J.L. Bos Ras oncogenes in human cancer: a review Cancer Res. 49 17 1989 4682 4689
36. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 mutations in human cancers Science 253 1991 49 53
37. A. Kohara, T. Suzuki, M. Honma, T. Ohwada, and M. Hayashi Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (MutaMouse) Mutat. Res. 515 2002 63 72